Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Clayton

Showing results (551-560 of 569) with videos related to

Pageof 57
Sort By:
Bioorganic & Medicinal Chemistry Letters|November 7, 2006
The discovery of 6-[2-(5-chloro-2-{[(2,4-difluorophenyl)methyl]oxy}phenyl)-1-cyclopenten-1-yl]-2-pyridinecarboxylic acid, GW848687X, a potent and selective prostaglandin EP1 receptor antagonist for the treatment of inflammatory painGerard M P Giblin, Rino A Bit, Susan H Brown, et al.
The Review of Scientific Instruments|April 4, 2024
Scintillation characteristics of the EJ-299-02H scintillatorN Floyd, Md T Hassan, Z Tang, et al.
Immunity|October 21, 2016
Antiviral CD8<sup>+</sup> T Cells Restricted by Human Leukocyte Antigen Class II Exist during Natural HIV Infection and Exhibit Clonal ExpansionSrinika Ranasinghe, Pedro A Lamothe, Damien Z Soghoian, et al.
The Review of Scientific Instruments|October 25, 2024
Cerium doped yttrium aluminum perovskite scintillator as an absolute ultracold neutron detectorM Krivoš, N C Floyd, Z Tang, et al.
The New England Journal of Medicine|February 1, 1996
A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertensionR J Barst, L J Rubin, W A Long, et al.
Physical Review Letters|August 8, 2018
Search for the Neutron Decay n→X+γ, Where X is a Dark Matter ParticleZ Tang, M Blatnik, L J Broussard, et al.
Circulation|March 18, 1997
Effects of long-term infusion of prostacyclin (epoprostenol) on echocardiographic measures of right ventricular structure and function in primary pulmonary hypertension. Primary Pulmonary Hypertension Study GroupA L Hinderliter, P W Willis, R J Barst, et al.
Npj Biomedical Innovations|April 24, 2026
Towards adaptive bioelectronic wound therapy with integrated real-time diagnostics and machine learning-driven closed-loop controlHoupu Li, Hsin-Ya Yang, Fan Lu, et al.
Ebiomedicine|July 30, 2025
SUDEP risk is influenced by longevity genomics: a polygenic risk score studyHelena Martins, James D Mills, Susanna Pagni, et al.
Frontiers in Neuroscience|October 4, 2023
Testing for pharmacogenomic predictors of ppRNFL thinning in individuals exposed to vigabatrinIsabelle Boothman, Lisa M Clayton, Mark McCormack, et al.
Pageof 57

Showing results (551-560 of 569) with videos related to

Sort By:
Pageof 57
Bioorganic & Medicinal Chemistry Letters|November 7, 2006
The discovery of 6-[2-(5-chloro-2-{[(2,4-difluorophenyl)methyl]oxy}phenyl)-1-cyclopenten-1-yl]-2-pyridinecarboxylic acid, GW848687X, a potent and selective prostaglandin EP1 receptor antagonist for the treatment of inflammatory painGerard M P Giblin, Rino A Bit, Susan H Brown, et al.
The Review of Scientific Instruments|April 4, 2024
Scintillation characteristics of the EJ-299-02H scintillatorN Floyd, Md T Hassan, Z Tang, et al.
Immunity|October 21, 2016
Antiviral CD8<sup>+</sup> T Cells Restricted by Human Leukocyte Antigen Class II Exist during Natural HIV Infection and Exhibit Clonal ExpansionSrinika Ranasinghe, Pedro A Lamothe, Damien Z Soghoian, et al.
The Review of Scientific Instruments|October 25, 2024
Cerium doped yttrium aluminum perovskite scintillator as an absolute ultracold neutron detectorM Krivoš, N C Floyd, Z Tang, et al.
The New England Journal of Medicine|February 1, 1996
A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertensionR J Barst, L J Rubin, W A Long, et al.
Physical Review Letters|August 8, 2018
Search for the Neutron Decay n→X+γ, Where X is a Dark Matter ParticleZ Tang, M Blatnik, L J Broussard, et al.
Circulation|March 18, 1997
Effects of long-term infusion of prostacyclin (epoprostenol) on echocardiographic measures of right ventricular structure and function in primary pulmonary hypertension. Primary Pulmonary Hypertension Study GroupA L Hinderliter, P W Willis, R J Barst, et al.
Npj Biomedical Innovations|April 24, 2026
Towards adaptive bioelectronic wound therapy with integrated real-time diagnostics and machine learning-driven closed-loop controlHoupu Li, Hsin-Ya Yang, Fan Lu, et al.
Ebiomedicine|July 30, 2025
SUDEP risk is influenced by longevity genomics: a polygenic risk score studyHelena Martins, James D Mills, Susanna Pagni, et al.
Frontiers in Neuroscience|October 4, 2023
Testing for pharmacogenomic predictors of ppRNFL thinning in individuals exposed to vigabatrinIsabelle Boothman, Lisa M Clayton, Mark McCormack, et al.
Pageof 57